Home › Companies › DISC MEDICINE INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and DISC MEDICINE INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 11, 2025: 5 items on DISC MEDICINE INC.’s Form 8-K, filed June 13, 2025: 2 approved · 3 passed (calculated).
Notable dissent: 1 director (13.7% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Ra Capital Management, L.P. (13F, 5.4%, as of September 30, 2026)
Explore DISC MEDICINE INC. in the interactive database Compare manager voting policies
These tallies are DISC MEDICINE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Georges Gemayel, Ph.D. | 30,122,499 | -- | -- | 920,582 | 1,076,876 | 97% | Passed (calculated) | — |
| Elect Director: Mark Chin, M.S., M.B.A. | 30,847,995 | -- | -- | 195,086 | 1,076,876 | 99.4% | Passed (calculated) | — |
| Elect Director: Liam Ratcliffe, M.D., Ph.D. | 26,803,620 | -- | -- | 4,239,461 | 1,076,876 | 86% | Passed (calculated) | — |
| 2. Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers | 30,801,342 | 235,453 | 6,286 | -- | 1,076,876 | 99.2% | Approved | — |
| 4. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm | 32,117,099 | 2,370 | -- | 488 | -- | 99.9% | Approved | — |
Source: DISC MEDICINE INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
187 asset managers disclosed a vote on at least one DISC MEDICINE INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of DISC MEDICINE INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following Class II nominees to the Board of Directors as set forth below: Georges Gemayel, Ph.D.
DISC MEDICINE INC.’s own tally for this item (“Elect Director: Georges Gemayel, Ph.D.”): 30,122,499 for, 920,582 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 9,811,990 for, 367,438 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,673,059 | 0 | 0 | 0 | For |
| Vanguard | 2,035,059 | 0 | 0 | 0 | For |
| T. Rowe Price | 986,983 | 0 | 0 | 0 | For |
| BlackRock | 839,565 | 0 | 0 | 0 | For |
| JPMorgan | 500,825 | 0 | 0 | 0 | For |
| State Street | 1,235 | 0 | 0 | 305,867 | Withhold |
| JANUS INVESTMENT FUND | 300,295 | 0 | 0 | 0 | For |
| Hartford | 204,510 | 0 | 0 | 0 | For |
| Charles Schwab | 196,005 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 181,818 | 0 | 0 | 0 | For |
| Victory Capital | 181,796 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 95,594 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,952 | 0 | 0 | 0 | For |
| Equitable | 65,278 | 0 | 0 | 0 | For |
| TIAA | 49,352 | 0 | 0 | 0 | For |
| John Hancock | 43,015 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 40,326 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 38,830 | 0 | 0 | 0 | For |
| Northwestern Mutual | 38,325 | 0 | 0 | 0 | For |
| MassMutual | 32,238 | 0 | 0 | 0 | For |
| Aberdeen | 32,061 | 0 | 0 | 0 | For |
| Brighthouse | 31,817 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 25,579 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 22,426 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 20,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following Class II nominees to the Board of Directors as set forth below: Liam Ratcliffe, M.D., Ph.D.
DISC MEDICINE INC.’s own tally for this item (“Elect Director: Liam Ratcliffe, M.D., Ph.D.”): 26,803,620 for, 4,239,461 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 8,759,622 for, 1,419,806 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,673,059 | 0 | 0 | 0 | For |
| Vanguard | 2,035,059 | 0 | 0 | 0 | For |
| T. Rowe Price | 986,983 | 0 | 0 | 0 | For |
| BlackRock | 687,270 | 0 | 0 | 152,295 | Mixed |
| JPMorgan | 500,825 | 0 | 0 | 0 | For |
| State Street | 852 | 0 | 0 | 306,250 | Withhold |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 300,295 | Withhold |
| Hartford | 204,510 | 0 | 0 | 0 | For |
| Charles Schwab | 196,005 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 181,818 | 0 | 0 | 0 | For |
| Victory Capital | 626 | 0 | 0 | 181,170 | Withhold |
| Bridge Builder Trust | 9,950 | 0 | 0 | 85,644 | Mixed |
| Columbia Threadneedle | 0 | 0 | 0 | 69,952 | Withhold |
| Equitable | 45,318 | 0 | 0 | 19,960 | Mixed |
| TIAA | 0 | 0 | 0 | 49,352 | Withhold |
| John Hancock | 34,783 | 0 | 0 | 8,232 | Mixed |
| Dimensional | 0 | 0 | 0 | 40,326 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 38,830 | 0 | 0 | 0 | For |
| Northwestern Mutual | 38,325 | 0 | 0 | 0 | For |
| MassMutual | 32,238 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 32,061 | Withhold |
| Brighthouse | 24,687 | 0 | 0 | 7,130 | Mixed |
| ALPS ETF Trust | 0 | 0 | 0 | 25,579 | Withhold |
| CARILLON SERIES TRUST | 0 | 0 | 0 | 22,426 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 20,902 | Withhold |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: To elect each of the following Class II nominees to the Board of Directors as set forth below: Mark Chin, M.S., M.B.A.
DISC MEDICINE INC.’s own tally for this item (“Elect Director: Mark Chin, M.S., M.B.A.”): 30,847,995 for, 195,086 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 10,136,083 for, 43,345 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,673,059 | 0 | 0 | 0 | For |
| Vanguard | 2,035,059 | 0 | 0 | 0 | For |
| T. Rowe Price | 986,983 | 0 | 0 | 0 | For |
| BlackRock | 839,565 | 0 | 0 | 0 | For |
| JPMorgan | 500,825 | 0 | 0 | 0 | For |
| State Street | 307,102 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 300,295 | 0 | 0 | 0 | For |
| Hartford | 204,510 | 0 | 0 | 0 | For |
| Charles Schwab | 196,005 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 181,818 | 0 | 0 | 0 | For |
| Victory Capital | 181,796 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 95,594 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,952 | 0 | 0 | 0 | For |
| Equitable | 65,278 | 0 | 0 | 0 | For |
| TIAA | 49,352 | 0 | 0 | 0 | For |
| John Hancock | 43,015 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 40,326 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 38,830 | 0 | 0 | 0 | For |
| Northwestern Mutual | 38,325 | 0 | 0 | 0 | For |
| MassMutual | 32,238 | 0 | 0 | 0 | For |
| Aberdeen | 32,061 | 0 | 0 | 0 | For |
| Brighthouse | 31,817 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 25,579 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 22,426 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 20,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 13 wordings of this item as funds reported it.
99.2% Approved · of votes cast
Description as filed by funds: TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.
DISC MEDICINE INC.’s own tally for this item (“2. Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers”): 30,801,342 for, 235,453 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers The stockholders of the Company approved, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers as described in the Proxy Statement.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,673,059 | 0 | 0 | 0 | For |
| Vanguard | 2,035,059 | 0 | 0 | 0 | For |
| T. Rowe Price | 986,983 | 0 | 0 | 0 | For |
| BlackRock | 839,565 | 0 | 0 | 0 | For |
| JPMorgan | 500,825 | 0 | 0 | 0 | For |
| State Street | 307,102 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 300,295 | 0 | 0 | 0 | For |
| Hartford | 204,510 | 0 | 0 | 0 | For |
| Charles Schwab | 196,005 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 181,818 | 0 | 0 | 0 | For |
| Victory Capital | 181,796 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 95,594 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,952 | 0 | 0 | 0 | For |
| Equitable | 65,278 | 0 | 0 | 0 | For |
| TIAA | 49,352 | 0 | 0 | 0 | For |
| John Hancock | 43,015 | 0 | 0 | 0 | For |
| Dimensional | 40,326 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 38,830 | 0 | 0 | 0 | For |
| Northwestern Mutual | 38,325 | 0 | 0 | 0 | For |
| MassMutual | 32,238 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 32,061 | 0 | 0 | Against |
| Brighthouse | 31,817 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 25,579 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 22,426 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 20,902 | 0 | 0 | 0 | For |
Fund voting reports, all 56 managers: 10,147,367 for, 32,061 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,207,405 | 0 | 0 | 0 | For |
| Atlas Venture Life Science Advisors, LLC | 2,384,456 | 0 | 0 | 0 | For |
| Wellington | 1,889,755 | 0 | 0 | 0 | For |
| Frazier Life Sciences Management, L.P. | 1,754,834 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 1,577,106 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,415,020 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,310,329 | 0 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 983,500 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 919,992 | 0 | 0 | 0 | For |
| Paradigm Biocapital Advisors LP | 839,713 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 775,364 | 0 | 0 | 0 | For |
| State Street | 735,897 | 0 | 0 | 0 | For |
| Woodline Partners LP | 719,420 | 0 | 0 | 0 | For |
| BlackRock | 683,852 | 0 | 0 | 0 | For |
| JPMorgan | 609,441 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 578,771 | 0 | 0 | 0 | For |
| Janus Henderson | 514,355 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 465,257 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 333,867 | 0 | 0 | 0 | For |
| Foresite Capital Management V, LLC | 299,069 | 0 | 0 | 0 | For |
| Victory Capital | 288,254 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 253,038 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 232,449 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 210,550 | 0 | 0 | 0 | For |
| Charles Schwab | 196,042 | 0 | 0 | 0 | For |
Institutional-manager reports, all 147 managers: 24,387,685 for, 200,329 against, 7,419 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.9% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO RECOMMEND, BY A NON-BINDING ADVISORY VOTE, THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 0 | -- |
| Hartford | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Northwestern Mutual | 0 | 0 | 0 | 0 | -- |
| MassMutual | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 0 | 0 | -- |
| ALPS ETF Trust | 0 | 0 | 0 | 0 | -- |
| CARILLON SERIES TRUST | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 56 managers: 10,138,392 1 year, 41,036 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | -- |
| ORBIMED ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| Paradigm Biocapital Advisors LP | 0 | 0 | 0 | 0 | -- |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Janus Henderson | 0 | 0 | 0 | 0 | -- |
| Foresite Capital Management V, LLC | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Saturn V Capital Management LP | 232,449 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Blue Owl Capital Holdings LP | 145,260 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Logos Global Management LP | 0 | 0 | 0 | 0 | -- |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Ensign Peak Advisors, Inc | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 134 managers: 386,409 for, 119 against, 17,087,155 1 year, 90,365 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 100.0% for (June 12, 2024 meeting) unchanged
Description as filed by funds: To ratify the appointment of Emst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
DISC MEDICINE INC.’s own tally for this item (“4. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm”): 32,117,099 for, 2,370 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4 – Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 10,179,428 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,673,059 | 0 | 0 | 0 | For |
| Vanguard | 2,035,059 | 0 | 0 | 0 | For |
| T. Rowe Price | 986,983 | 0 | 0 | 0 | For |
| BlackRock | 839,565 | 0 | 0 | 0 | For |
| JPMorgan | 500,825 | 0 | 0 | 0 | For |
| State Street | 307,102 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 300,295 | 0 | 0 | 0 | For |
| Hartford | 204,510 | 0 | 0 | 0 | For |
| Charles Schwab | 196,005 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 181,818 | 0 | 0 | 0 | For |
| Victory Capital | 181,796 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 95,594 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 69,952 | 0 | 0 | 0 | For |
| Equitable | 65,278 | 0 | 0 | 0 | For |
| TIAA | 49,352 | 0 | 0 | 0 | For |
| John Hancock | 43,015 | 0 | 0 | 0 | For |
| Dimensional | 40,326 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 38,830 | 0 | 0 | 0 | For |
| Northwestern Mutual | 38,325 | 0 | 0 | 0 | For |
| MassMutual | 32,238 | 0 | 0 | 0 | For |
| Aberdeen | 32,061 | 0 | 0 | 0 | For |
| Brighthouse | 31,817 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 25,579 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 22,426 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 20,902 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 34,581,222 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 10.62% |
| 2 | Vanguard | 5.88% |
| 3 | T. Rowe Price | 2.85% |
| 4 | BlackRock | 2.43% |
| 5 | JPMorgan | 1.45% |
| 6 | State Street | 0.89% |
| 7 | JANUS INVESTMENT FUND | 0.87% |
| 8 | Hartford | 0.59% |
| 9 | Charles Schwab | 0.57% |
| 10 | MUTUAL FUND SERIES TRUST | 0.53% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 9.27% |
| 2 | Atlas Venture Life Science Advisors, LLC | 6.90% |
| 3 | Wellington | 5.46% |
| 4 | Frazier Life Sciences Management, L.P. | 5.07% |
| 5 | RA CAPITAL MANAGEMENT, L.P. | 4.56% |
| 6 | ORBIMED ADVISORS LLC | 4.09% |
| 7 | T. Rowe Price | 3.79% |
| 8 | Bain Capital Life Sciences Investors, LLC | 2.84% |
| 9 | Siren, L.L.C. | 2.66% |
| 10 | Paradigm Biocapital Advisors LP | 2.43% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR (Fidelity) | 3,224,381 | 9.32% | Form 13F, quarter ended March 31, 2025 |
| AI DMI LLC | 3,018,460 | 8.73% | Schedule 13D, filed October 22, 2025 |
| Entities affiliated with Atlas Venture Fund | 2,551,238 | 7.38% | Proxy statement (DEF 14A), proxy filed April 24, 2025 |
| Wellington Management | 2,343,499 | 6.78% | Form 13F, quarter ended March 31, 2025 |
| FMR LLC | 2,259,437 | 6.53% | Proxy statement (DEF 14A), proxy filed April 24, 2025 |
| RA Capital Management, L.P. | 2,228,924 | 6.45% | Schedule 13G, filed January 7, 2026 |
| BlackRock | 2,094,560 | 6.06% | Form 13F, quarter ended March 31, 2025 |
| Entities affiliated with Wellington Management Group LLP | 1,995,405 | 5.77% | Proxy statement (DEF 14A), proxy filed April 24, 2025 |
| Entities affiliated with Frazier Life Sciences Management LP | 1,754,834 | 5.07% | Proxy statement (DEF 14A), proxy filed April 24, 2025 |
| ORBIMED ADVISORS LLC | 1,556,369 | 4.50% | Schedule 13D, filed March 12, 2025 |
Percentages above are of 34,581,222 shares outstanding, as reported by DISC MEDICINE INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At DISC MEDICINE INC.'s shareholder meeting held June 11, 2025, in the 2024-2025 proxy season, 187 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,553 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED… — DISC MEDICINE INC.'s filing reports the proposal as approved, with 99.2% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: DISC MEDICINE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DISC MEDICINE INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
DISC MEDICINE INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “DISC MEDICINE (IRON) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/disc-medicine-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.